Melatonin directly binds and inhibits death‐associated protein kinase 1 function in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Death‐associated protein kinase 1 (DAPK1) is upregulated in the brains of human Alzheimer's disease (AD) patients compared with normal subjects, and aberrant DAPK1 regulation is implicated in the development of AD. However, little is known about whether and how DAPK1 function is regulated in AD. Here, we identified melatonin as a critical regulator of DAPK1 levels and function. Melatonin significantly decreases DAPK1 expression in a post‐transcriptional manner in neuronal cell lines and mouse primary cortical neurons. Moreover, melatonin directly binds to DAPK1 and promotes its ubiquitination, resulting in increased DAPK1 protein degradation through a proteasome‐dependent pathway. Furthermore, in tau‐overexpressing mouse brain slices, melatonin treatment and the inhibition of DAPK1 kinase activity synergistically decrease tau phosphorylation at multiple sites related to AD. In addition, melatonin and DAPK1 inhibitor dramatically accelerate neurite outgrowth and increase the assembly of microtubules. Mechanistically, melatonin‐mediated DAPK1 degradation increases the activity of Pin1, a prolyl isomerase known to play a protective role against tau hyperphosphorylation and tau‐related pathologies. Finally, elevated DAPK1 expression shows a strong correlation with the decrease in melatonin levels in human AD brains. Combined, these results suggest that DAPK1 regulation by melatonin is a novel mechanism that controls tau phosphorylation and function and offers new therapeutic options for treating human AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodHyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Self-citationTau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Tau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodTau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
The microtubule binding domain of tau protein
Lee, G., Neve, R. L., & Kosik, K. S. (1989) · Neuron · doi:10.1016/0896-6273(89)90050-0 · Cited by 500 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodCandidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease
Li, H., Wetten, S., Li, L., St. Jean, P. L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M. R., Briley, J. D., Borrie, M., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.3 · Cited by 499 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodDAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M. M., Belal, C., Wang, M., Jia, N., Zhang, W., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.055 · Cited by 493 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodLeroy, K., Yilmaz, Z., & Brion, J. ‐. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00795.x · Cited by 404
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodAge-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., & Davies, P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1065-09.2009 · Cited by 329
Liu, R.-Y., Zhou, J.-N., van Heerikhuize, J., Hofman, M. A., & Swaab, D. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5394 · Cited by 304
Pei, J.-J., Braak, H., An, W.-L., Winblad, B., Cowburn, R. F., Iqbal, K., & Grundke-Iqbal, I. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00488-6 · Cited by 247
Lee, T. H., Chen, C.-H., Suizu, F., Huang, P., Schiene-Fischer, C., Daum, S., Zhang, Y. J., Goate, A., Chen, R.-H., Zhou, X. Z., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.005 · Cited by 183
Self-citationDaily rhythm of serum melatonin in patients with dementia of the degenerate type
Uchida, K., Okamoto, N., Ohara, K., & Morita, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00086-8 · Cited by 138 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodKim, B. M., You, M.-H., Chen, C.-H., Lee, S., Hong, Y., Hong, Y., Kimchi, A., Zhou, X. Z., & Lee, T. H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.216 · Cited by 98 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
MethodSelf-citationIdentification of a novel melatonin-binding nuclear receptor: Vitamin D receptor
Fang, N., Hu, C., Sun, W., Xu, Y., Gu, Y., Wu, L., Peng, Q., Reiter, R. J., & Liu, L. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12618 · Cited by 46 · cited 2×
“35,55 Our previous research has demonstrated the efficacy and specificity of this compound as it alleviates DAPK1 activity-dependent neuronal death.37 Recombinant DAPK1 (1-666) was incubated with GST-Pin1 in the presence of DMSO, melatonin, or DAPK1-i and ATP, followed by immunoblotting analysis.”
Method
Cited by
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Chen, D., Zhang, T., & Lee, T. H. (2020) · Biomolecules · doi:10.3390/biom10081158 · Cited by 140
“Inhibiting tau hyperphosphorylation Animal PP-2A Pharma [78] Inhibiting apoptosis Cell Calpain/CDK5 Pharma [79] Inhibiting tau hyperphosphorylation Cell DAPK1/Pin1 Physio [80]”
BackgroundSelf-citationNew therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Zhang, F., Zhong, R.-J., Cheng, C., Li, S., & Le, W.-D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00565-5 · Cited by 105
“Melatonin is a hormone mainly generated in the pineal gland that regulates the circadian rhythm and shows neuroprotective effects against tau pathology [74].”
BackgroundBridging neurotrophic factors and bioactive peptides to Alzheimer’s disease
Wei, M., Wu, T., & Chen, N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102177 · Cited by 31
Metadata
- Authors
- Chen, D., Mei, Y., Kim, N., Lan, G., Gan, C., Fan, F., Zhang, T., Xia, Y., Wang, L., Lin, C., Ke, F., Zhou, X. Z., Lu, K. P., & Lee, T. H.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2020-05-27
- Volume
- 69
- Issue
- 2
- Pages
- e12665-e12665
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W3021576841
- Cited by
- 59
- References
- 19
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.